EP0902836A4 - Ribozymes asymetriques en forme de tete de marteau - Google Patents

Ribozymes asymetriques en forme de tete de marteau

Info

Publication number
EP0902836A4
EP0902836A4 EP97913997A EP97913997A EP0902836A4 EP 0902836 A4 EP0902836 A4 EP 0902836A4 EP 97913997 A EP97913997 A EP 97913997A EP 97913997 A EP97913997 A EP 97913997A EP 0902836 A4 EP0902836 A4 EP 0902836A4
Authority
EP
European Patent Office
Prior art keywords
compound
hammerhead ribozymes
man
asymmetric
asymmetric hammerhead
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97913997A
Other languages
German (de)
English (en)
Other versions
EP0902836A1 (fr
Inventor
Philip Hendry
Maxine J Mccall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gene Shears Pty Ltd
Original Assignee
Gene Shears Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gene Shears Pty Ltd filed Critical Gene Shears Pty Ltd
Publication of EP0902836A1 publication Critical patent/EP0902836A1/fr
Publication of EP0902836A4 publication Critical patent/EP0902836A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate

Abstract

L'invention concerne un composé ayant la formule (I). Dans cette formule, N peut être un nucléotide, n est égal à 1-5 et n' est égal à 1-3. Ces ribozymes asymétriques présentent des vitesses de scission plus élevées que la normale. Le composé peut être lié par covalence à un agent d'administration. L'invention concerne, en outre, une composition qui comprend le composé en association avec un vecteur acceptable. L'invention concerne également une méthode pour scinder une séquence cible d'ARN avec le composé décrit ci-dessus. L'invention concerne, également, une méthode pour traiter une maladie associée à un ARN particulier, chez un humain ou chez un animal, qui consiste à administrer le composé à cet humain ou à cet animal. En outre, l'invention concerne un réactif de diagnostic qui comprend le composé.
EP97913997A 1996-04-02 1997-04-02 Ribozymes asymetriques en forme de tete de marteau Withdrawn EP0902836A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1465996P 1996-04-02 1996-04-02
US62703396A 1996-04-02 1996-04-02
US14659P 1996-04-02
US627033 1996-04-02
PCT/AU1997/000210 WO1997037013A1 (fr) 1996-04-02 1997-04-02 Ribozymes asymetriques en forme de tete de marteau

Publications (2)

Publication Number Publication Date
EP0902836A1 EP0902836A1 (fr) 1999-03-24
EP0902836A4 true EP0902836A4 (fr) 2004-12-22

Family

ID=26686341

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97913997A Withdrawn EP0902836A4 (fr) 1996-04-02 1997-04-02 Ribozymes asymetriques en forme de tete de marteau

Country Status (5)

Country Link
EP (1) EP0902836A4 (fr)
JP (1) JP2000509969A (fr)
AU (1) AU721758B2 (fr)
CA (1) CA2250857A1 (fr)
WO (1) WO1997037013A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004512810A (ja) * 1999-08-31 2004-04-30 サーナ・セラピューティクス・インコーポレイテッド 核酸に基づく遺伝子発現の調節剤
WO2001030362A2 (fr) * 1999-10-26 2001-05-03 Immusol Incorporated Therapie ribozymique destinee au traitement de maladies proliferantes de la peau et des yeux
GB0224663D0 (en) * 2002-10-23 2002-12-04 Isis Innovation DNAzyme

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019789A1 (fr) * 1990-06-19 1991-12-26 Commonwealth Scientific And Industrial Research Organisation Endonucleases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU687736B2 (en) * 1992-05-11 1998-03-05 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting viral replication
EP0641212A4 (fr) * 1992-05-14 1997-05-21 Ribozyme Pharm Inc Procede et reactif destines a empecher l'evolution du cancer.
EP0654077A4 (fr) * 1992-07-17 1996-03-13 Ribozyme Pharm Inc Procede et reactif pour le traitement de maladies chez les animaux.
AU5334294A (en) * 1993-10-15 1995-05-04 Dkfz Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Asymmetric hammerhead ribozymes and nucleotide sequences for their construction

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019789A1 (fr) * 1990-06-19 1991-12-26 Commonwealth Scientific And Industrial Research Organisation Endonucleases

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
AMIRI KHALED M A ET AL: "Global conformation of a self-cleaving hammerhead RNA", BIOCHEMISTRY, vol. 33, no. 45, 1994, pages 13172 - 13177, XP002303024, ISSN: 0006-2960 *
DENMAN ROBERT B ET AL: "Differential activity of trans-acting hammerhead ribozymes targeted to beta amyloid peptide precursor mRNA by altering the symmetry of helices I and III", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, vol. 323, no. 1, 1995, pages 71 - 78, XP002303023, ISSN: 0003-9861 *
HENDRY PHILIP ET AL: "A comparison of the in vitro activity of DNA-armed and all-RNA hammerhead ribozymes", NUCLEIC ACIDS RESEARCH, vol. 23, no. 19, 1995, pages 3928 - 3936, XP002303026, ISSN: 0305-1048 *
HENDRY PHILIP ET AL: "Unexpected anisotropy in substrate cleavage rates by asymmetric hammerhead ribozymes", NUCLEIC ACIDS RESEARCH, vol. 24, no. 14, 15 July 1996 (1996-07-15), pages 2679 - 2684, XP002303027, ISSN: 0305-1048 *
See also references of WO9737013A1 *
TABLER M ET AL: "A THREE-NUCLEOTIDE HELIX I IS SUFFICIENT FOR FULL ACTIVITY OF A HAMMERHEAD ROBOZYME: ADVANTAGES OF AN ASYMMETRIC DESIGN", NUCLEIC ACIDS RESEARCH, vol. 22, no. 19, 1994, pages 3958 - 3965, XP002051226, ISSN: 0305-1048 *
ZOUMADAKIS M ET AL: "Comparative analysis of cleavage rates after systematic permutation of the NUX consensus target motif for hammerhead ribozymes.", NUCLEIC ACIDS RESEARCH, vol. 23, no. 7, 11 April 1995 (1995-04-11), pages 1192 - 1196, XP002303025, ISSN: 0305-1048 *

Also Published As

Publication number Publication date
CA2250857A1 (fr) 1997-10-09
AU2145097A (en) 1997-10-22
WO1997037013A1 (fr) 1997-10-09
EP0902836A1 (fr) 1999-03-24
JP2000509969A (ja) 2000-08-08
AU721758B2 (en) 2000-07-13

Similar Documents

Publication Publication Date Title
EP0761680A3 (fr) Composés de tétrazole ayant une activité inhibante d'enzyme convertissant l'Interleukine-1bêta
DE60023841D1 (de) Verfahren zur herstellung alkylierter salicylamide
CA2273907A1 (fr) Composition d'un agent de traitement de surface de materiau metallique et le procede de traitement
WO1999058555A3 (fr) Promedicaments de propofol solubles dans l'eau
NZ594877A (en) Nucleic acids and proteins from streptococcus groups A & B
CA2209048A1 (fr) Compositions aqueuses de polymeres sylilates alkoxysilane alkoxy durcissable se conservant plus longtemps a l'etalage
EP1359150A3 (fr) Procédé et intermediaires pour la préparation de 7-alkyltriazolopyrimidines fongicides
PT1053313E (pt) Oligonucleotidos ''antisense'' optimizados complementares de sequencias de dna metiltransferase
WO2000073764A3 (fr) Compositions et methodes pour l'utilisation therapeutique d'une sequence associee au gene atonal dans le traitement de la surdite, de l'osteoarthrite et d'une proliferation cellulaire anormale
GB9916405D0 (en) Compounds for mass spectrometry
AU8243198A (en) Remedies for solid tumor containing wilms' tumor gene (wt1) expression inhibitors
CA2015235A1 (fr) Povidone-iode utilise comme agent prophylactique antimicrobien ophtalmique chez les nouveau-nes
BG104883A (en) Human bmp-7 promoter and method for exploring bone-related substance by using the same
EP0902836A4 (fr) Ribozymes asymetriques en forme de tete de marteau
WO1999024077A3 (fr) Compositions et procedes d'administration ciblee de facteurs
WO1999066075A3 (fr) Methode diagnostique basee sur la quantification d'adn extramitochondrial
WO1996021015A3 (fr) Combinaison de vecteurs d'administration de genes
FR2739098B1 (fr) Procede d'acylation d'un compose aromatique
AU2180501A (en) Novel DNA polymerase inhibitors, mikanolide and dihydromikanolide
AP2000001937A0 (en) Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway.
CA2135200A1 (fr) Gene s d'un coronavirus canin et applications
IE45285L (en) Polyribonucleotides.
ES2085767T3 (es) Aumento de la actividad catalitica de las ribozimas por un oligonucleotido facilitador proximo.
AU7974791A (en) Identification of novel drugs and reagents
AU2002211577A1 (en) Protecting therapeutic compositions from host-mediated inactivation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981102

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GENE SHEARS PTY LIMITED

A4 Supplementary search report drawn up and despatched

Effective date: 20041108

17Q First examination report despatched

Effective date: 20050126

17Q First examination report despatched

Effective date: 20050126

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071215